Oculus Innovative Sciences Inc (NASDAQ:OCLS)

CAPS Rating: 2 out of 5

The Company has developed and it manufactures and markets, a family of products intended to prevent and treat infections in chronic and acute wounds.


Player Avatar zzlangerhans (99.84) Submitted: 2/24/2013 5:38:25 PM : Outperform Start Price: $4.13 OCLS Score: +11.19

Oculus has continued their choppy three year decline of late with a recent acceleration of downward momentum after the last earnings report. While sales were typically disappointing and showed a foreboding sequential decline in Innovacyn revenues, I think the real pressure on the stock came from the company's declared intention to engineer a reverse split to maintain their Nasdaq listing.

Playing Oculus for a rebound is a risky game that has already cost me the equivalent of all the points I've made on my multiple correct calls. I don't have much respect for the technology here but I have seen enough manipulated spikes in this stock to make it difficult to resist at depressed prices.

Featured Broker Partners